News & Updates

Show Multimedia Only
Polygenic risk score shows promise in predicting future breast cancer events
Polygenic risk score shows promise in predicting future breast cancer events
13 hours ago byAudrey Abella

A retrospective analysis shows the potential of the 313-SNP breast cancer (BC) polygenic risk score (PRS313) blood test to predict future in situ or invasive breast disease in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

Polygenic risk score shows promise in predicting future breast cancer events
13 hours ago